Triglimibrit 1mg/500mg/0.3mg Tablet SR
Manufacturer
Elbrit Life Sciences
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Key Information
Short Description
Triglimibrit 1mg/500mg/0.3mg Tablet SR is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Dosage Form
Tablet SR
Introduction
Triglimibrit 1mg/500mg/0.3mg Tablet SR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Triglimibrit 1mg/500mg/0.3mg Tablet SR is to be taken empty stomach.
How it works
Triglimibrit 1mg/500mg/0.3mg Tablet SR is a combination of three antidiabetic medicines:
Quick Tips
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Related Medicines
Voglibite-GM 1/0.3 Tablet
Vogli-GM 1 Forte Tablet
Glimisave MV 1.3 Tablet
Trivoglitor Forte 1 Tablet SR
Gluconorm VG 1 Plus Tablet SR
Diapride M1 HV Tablet
Voglivil GM 1/0.3 Tablet SR
Wonride MV 1 Tablet SR
Trivogo 1/0.3mg Tablet SR
Azulix MV 1mg/500mg/0.3mg Tablet SR
Frequently asked questions
What is Triglimibrit 1mg/500mg/0.3mg Tablet SR?
Triglimibrit 1mg/500mg/0.3mg Tablet SR is a combination medication containing Glimepiride, Metformin and Voglibose for the treatment of type 2 diabetes mellitus (DM). It works by improving blood glucose levels in adults through diet and exercise. Glimepiride increases insulin release, metformin decreases glucose production and Voglibose inhibits postprandial glucose absorption.
What are the possible side effects of Triglimibrit 1mg/500mg/0.3mg Tablet SR?
Common side effects include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection. It is crucial to seek immediate medical attention if experiencing severe adverse reactions like dizziness or difficulty breathing.
Are there any specific conditions in which Triglimibrit 1mg/500mg/0.3mg Tablet SR should not be taken?
Triglimibrit 1mg/500mg/0.3mg Tablet SR is contraindicated for patients with known allergies to the ingredients or excipients in this medicine. It's also advised against use in individuals with moderate to severe kidney disease and inflammatory bowel disease, ulcerative colitis, and underlying metabolic acidosis including diabetic ketoacidosis.
Is it safe to take alcohol while I am also taking Triglimibrit 1mg/500mg/0.3mg Tablet SR?
No, alcohol consumption while on this medication is not recommended as it can lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Can the use of Triglimibrit 1mg/500mg/0.3mg Tablet SR cause hypoglycemia?
Yes, Triglimibrit 1mg/500mg/0.3mg Tablet SR can cause hypoglycemia (low blood sugar level). Symptoms include dizziness, headache, irritability, hunger, sweating, fast heart rate and feeling anxious or shaky. It may occur more frequently if you miss meals, drink alcohol, over-exercise or take other antidiabetic medications in combination.
What are the instructions for the storage and disposal of Triglimibrit 1mg/500mg/0.3mg Tablet SR?
Store this medicine in its original packaging, tightly closed. Refer to the accompanying label or packaging for specific storage instructions. Do not dispose of the medication down the drain. Ensure that it is inaccessible to children, pets and other individuals.
